Roberttanser
382 posts
Mar 13, 2026
12:15 AM
|
Super Zhewitra is a combination prescription medication that pairs vardenafil (a PDE5 inhibitor for erectile dysfunction) with dapoxetine (a short?acting SSRI to help delay ejaculation). Unlike single?ingredient drugs like Viagra or Levitra, the combination product itself doesn’t have a well?documented specific “creation date” in medical literature or regulatory filings. What’s known is that vardenafil and dapoxetine were developed separately and later combined into products like Super Zhewitra by pharmaceutical manufacturers such as Sunrise Remedies in India.
Vardenafil — the active PDE5 inhibitor in Super Zhewitra — was introduced as a treatment for erectile dysfunction in the early 2000s as Levitra, following the success of sildenafil (Viagra).
Dapoxetine — the component that delays ejaculation — was developed and approved for treating premature ejaculation in the 2000s as well, gaining regulatory approvals in various countries.
Combination products like SUPER ZHEWITRA began appearing in the pharmaceutical market after both active ingredients were widely used individually, especially in the mid? to late?2010s, as manufacturers sought to address multiple sexual dysfunction issues with one tablet. While there’s no precise public record of an exact launch year for Super Zhewitra itself, its availability and widespread manufacture in markets such as India have been noted over the last decade.
In summary, Super Zhewitra was created after the individual components’ approvals, combining established drugs to treat both erectile dysfunction and premature ejaculation in a single formulation, and has been manufactured and marketed in recent years by companies like Sunrise Remedies.
|
